Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

5 results
Display

Molecularly Targeted Therapy for Lung Cancer : Recent Topics

Saijo N

Many clinical trials of molecular target drugs have been done against advanced lung cancer, however, majority did not meet the primary endpoint. Positive studies of EGFR-TKI such as BR21 and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Role of Pharmacoethnicity in the Development of Cytotoxic and Molecular Targeted Drugs in Oncology

Saijo N

The effective and toxic ranges of anticancer drugs are very narrow and, in some cases, inverted. Thus determination of the most appropriate dosage and schedule of administration is crucial for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of Small Cell Lung Cancer

Horiike A, Saijo N

  • KMID: 2166175
  • Cancer Res Treat.
  • 2003 Jun;35(3):177-180.
Among patients with lung cancer, approximately 15% have small cell lung cancer (SCLC), SCLC is usually staged as either limited and extensive. Extensive-stage SCLC is treated primarily with chemotherapy. A...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Present Status and Problems on Molecular Targeted Therapy of Cancer

Saijo N

  • KMID: 2167581
  • Cancer Res Treat.
  • 2012 Mar;44(1):1-10.
Numerous clinical trials of molecular targeted drugs for cancer have been conducted, with remarkable results for certain drugs and accumulation of "negative data" causing a hitch in the development plan...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Antitumor Activity of Oxaliplatin, 5-FU and Paclitaxel Given Alone or in Combination with ZD1839 in Human Gastric Carcinoma Cells in vitro

Jang JH, Lee SH, Kang JH, Sun HS, Nishio K, Saijo N, Kuh HJ

  • KMID: 1972943
  • Cancer Res Treat.
  • 2002 Oct;34(5):372-381.
PURPOSE: Oxaliplatin (LOHP), 5-FU, and paclitaxel (PTX) are considered highly active against advanced gastric carcinomas, and the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, ZD1839 is considered as a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr